A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System

References

• GBD 2019 Blindness and Vision Impairement Collaborators. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to vision 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9:e144–e160. doi:10.1016/S2214-109X(20)30489-7
   PubMed Web of Science ®Google Scholar
• Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–2090. doi:10.1016/j.ophtha.2014.05.013
   PubMed Web of Science ®Google Scholar
• Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390:2183–2193. doi:10.1016/S0140-6736(17)31469-1
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429–440. doi:10.1016/S0002-9394(00)00538-9
   PubMed Web of Science ®Google Scholar
• Razeghinejad MR, Myers JS, Katz LJ. Iatrogenic glaucoma secondary to medications. Am J Med. 2011;124:20–25. doi:10.1016/j.amjmed.2010.08.011
   PubMed Web of Science ®Google Scholar
• World Health Organization. The Safety of Medicines in Public Health Programmes: Pharmacovigilance an Essential Tool. Geneva, Switzerland: WHO Press, World Health Organization; 2006.
   Google Scholar
• Ramirez E, Carcas AJ, Borobia AM, et al. A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients. Clin Pharmacol Ther. 2010;87:74–86. doi:10.1038/clpt.2009.185
   PubMed Web of Science ®Google Scholar
• Kambara H, Oyama S, Inada A, Niinomi I, Wakabayashi T, Hosohata K. Current status of adverse event profile of tacrolimus in patients with solid organ transplantation from a pharmacovigilance study. Int J Clin Pharmacol Ther. 2021;59:753–759. doi:10.5414/CP204016
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Ueno S, Nakatsuji T, et al. Safety profiles of new xanthine oxidase inhibitors: a post-marketing study. Int J Clin Pharmacol Ther. 2021;59:372–377. doi:10.5414/CP203898
   PubMed Web of Science ®Google Scholar
• Kambara H, Hosohata K, Nakatsuji T, et al. Safety profile of vonoprazan compared with proton pump inhibitors: insight from a pharmacovigilance study. Die Pharmazie. 2020;75:527–530. doi:10.1691/ph.2020.0604
   PubMed Web of Science ®Google Scholar
• Niinomi I, Hosohata K, Oyama S, Inada A, Hirai T, Iwanaga K. Drug-induced thrombotic microangiopathy using the Japanese pharmacovigilance database. Int J Clin Pharmacol Ther. 2020;58:543–549. doi:10.5414/CP203724
   PubMed Web of Science ®Google Scholar
• Niinomi I, Hosohata K, Oyama S, Inada A, Wakabayashi T, Iwanaga K. Pharmacovigilance assessment of drug-induced acute pancreatitis using a spontaneous reporting database. Int J Toxicol. 2019;38:487–492. doi:10.1177/1091581819870717
   PubMed Web of Science ®Google Scholar
• Inada A, Oyama S, Niinomi I, Wakabayashi T, Iwanaga K, Hosohata K. Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: subgroup analysis based on a Japanese spontaneous database. Clin Pharm Ther. 2019;44:775–779. doi:10.1111/jcpt.13001
   Google Scholar
• Hosohata K, Oyama S, Niinomi I, Wakabayashi T, Inada A, Iwanaga K. Comparison of safety profiles of new oral anticoagulants with warfarin using the Japanese spontaneous reporting database. Clin Drug Invest. 2019;39:665–670. doi:10.1007/s40261-019-00788-3
   PubMed Web of Science ®Google Scholar
• Hosohata K, Inada A, Oyama S, Niinomi I, Wakabayashi T, Iwanaga K. Adverse cutaneous drug reactions associated with old- and new- generation antiepileptic drugs using the Japanese pharmacovigilance database. Clin Drug Invest. 2019;39:363–368. doi:10.1007/s40261-019-00754-z
   PubMed Web of Science ®Google Scholar
• Hosohata K, Inada A, Oyama S, Furushima D, Yamada H, Iwanaga K. Surveillance of drugs that most frequently induce acute kidney injury: a pharmacovigilance approach. Clin Pharm Ther. 2019;44:49–53. doi:10.1111/jcpt.12748
   Google Scholar
• Hashemi H, Khabazkhoob M, Nabovati P, et al. The prevalence of age-related eye disease in an elderly population. Ophthalmic Epidemiol. 2017;24:222–228. doi:10.1080/09286586.2016.1270335
   PubMed Web of Science ®Google Scholar
• Castellanos-Perilla N, Garcia-Cifuentes E, Pineda-Ortega J, et al. Self-reported glaucoma prevalence and related factors, contribution to reported visual impairment, and functional burden in a cross-sectional study in Colombia. Int Ophthalmol. 2023;43:2447–2455. doi:10.1007/s10792-023-02643-z
   PubMed Web of Science ®Google Scholar
• Bongaarts J. Human population growth and the demographic transition. Philos Trans R Soc Lond B Biol Sci. 2009;364:2985–2990. doi:10.1098/rstb.2009.0137
   PubMed Web of Science ®Google Scholar
• Chen YH, Gepstein R, Sharief L, et al. Outcome and risk of ocular complications of managing children with chronic anterior uveitis with topical rimexolone 1. Int Ophthalmol. 2020;40:1061–1068. doi:10.1007/s10792-020-01358-9
   PubMed Web of Science ®Google Scholar
• Shokoohi-Rad S, Daneshvar R, Jafarian-Shahri M, Rajaee P. Comparison between betamethasone, fluorometholone and loteprednol etabonate on intraocular pressure in patients after keratorefractive surgery. J Curr Ophthalmol. 2018;30(2):130–135. doi:10.1016/j.joco.2017.11.008
   PubMed Web of Science ®Google Scholar
• Kuley B, Storey PP, Pancholy M, et al. Ocular hypertension following 40 mg sub-tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone. Can J Ophthalmol. 2020;55:480–485. doi:10.1016/j.jcjo.2020.06.021
   PubMed Web of Science ®Google Scholar
• Tripathi RC, Tripathi BJ, Haggerty C. Drug-induced glaucomas: mechanism and management. Drug Safety. 2003;26:749–767. doi:10.2165/00002018-200326110-00002
   PubMed Web of Science ®Google Scholar
• Browne MJ, Zakrzewski H, Carleton B, Etminan M, Mikelberg FS. Association of gabapentin or pregabalin use and incidence of acute angle-closure glaucoma. J Glaucoma. 2019;28:777–779. doi:10.1097/IJG.0000000000001330
   PubMed Web of Science ®Google Scholar
• Chintalapudi SR, Maria D, Di Wang X, Bailey JNC, Consortium N, et al.; International Glaucoma Genetics c. Systems genetics identifies a role for cacna2d1 regulation in elevated intraocular pressure and glaucoma susceptibility. Nat Commun. 2017;8:1755. doi:10.1038/s41467-017-00837-5
   PubMed Web of Science ®Google Scholar
• Gabrielle PH, Nguyen V, Wolff B, et al. Intraocular pressure changes and vascular endothelial growth factor inhibitor use in various retinal diseases: long-term outcomes in routine clinical practice: data from the fight retinal blindness! Registry. Ophthalmology Retina. 2020;4:861–870. doi:10.1016/j.oret.2020.06.020
   PubMedGoogle Scholar
• Spini A, Giometto S, Donnini S, et al. Risk of intraocular pressure increase with intravitreal injections of vascular endothelial growth factor inhibitors: a cohort study. Am J Ophthalmol. 2023;248:45–50. doi:10.1016/j.ajo.2022.11.015
   PubMed Web of Science ®Google Scholar
• Chang YH, Chien LN, Chen WT, Lin IC. Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: a nationwide population-based cohort study. PLoS One. 2022;17:e0267088. doi:10.1371/journal.pone.0267088
   PubMed Web of Science ®Google Scholar
• Mansoori T, Agraharam SG, Manwani S, Balakrishna N. Intraocular pressure changes after intravitreal bevacizumab or ranibizumab injection: a retrospective study. J Curr Ophthalmol. 2021;33:6–11. doi:10.4103/JOCO.JOCO_5_20
   PubMed Web of Science ®Google Scholar
• Piette J, Yaniv M. Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the sv40 and c-fos enhancers. EMBO J. 1987;6:1331–1337. doi:10.1002/j.1460-2075.1987.tb02372.x
   PubMed Web of Science ®Google Scholar
• Reffatto V, Gupta PK, Williams T, Schmitz-Brown ME, Vizzeri G. Fk506 treatment prevents retinal nerve fiber layer thinning in organ-transplanted glaucoma patients: a retrospective longitudinal study. Cureus. 2021;13:e18192. doi:10.7759/cureus.18192
   PubMed Web of Science ®Google Scholar
• Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007;18:129–133. doi:10.1097/ICU.0b013e32808738d5
   PubMed Web of Science ®Google Scholar
• Vadot E, Grateau C. [The frequency of acute glaucoma crises. Implications for the detection of the risk of angle-closure]. Bull Soc Ophtalmol Fr. 1989;89:675–677. French.
   PubMedGoogle Scholar
• Mandak JS, Minerva P, Wilson TW, Smith EK. Angle closure glaucoma complicating systemic atropine use in the cardiac catheterization laboratory. Catheter Cardiovasc Diag. 1996;39:262–264. doi:10.1002/(SICI)1097-0304(199611)39:3<262::AID-CCD11>3.0.CO;2-H
   PubMedGoogle Scholar
• Oksuz H, Tamer C, Akoglu S, Duru M. Acute angle-closure glaucoma precipitated by local tiotropium absorption. Pulm Pharmacol Ther. 2007;20:627–628. doi:10.1016/j.pupt.2006.07.002
   PubMed Web of Science ®Google Scholar
• Jimenez-Jimenez FJ, Orti-Pareja M, Zurdo JM. Aggravation of glaucoma with fluvoxamine. Ann Pharmacother. 2001;35:1565–1566. doi:10.1345/aph.1Z440
   PubMed Web of Science ®Google Scholar
• Shen E, Farukhi S, Schmutz M, Mosaed S. Acute angle-closure glaucoma associated with aripiprazole in the setting of plateau iris configuration. J Glaucoma. 2018;27:e40–e43. doi:10.1097/IJG.0000000000000836
   PubMed Web of Science ®Google Scholar
• Bennett HG, Wyllie AM. Paroxetine and acute angle-closure glaucoma. Eye. 1999;13(5):691–692. doi:10.1038/eye.1999.196
   PubMedGoogle Scholar
• Matsuo M, Sano I, Ikeda Y, Fujihara E, Tanito M. Intraoperative floppy-iris syndrome associated with use of antipsychotic drugs. Can J Ophthalmol. 2016;51:294–296. doi:10.1016/j.jcjo.2016.02.008
   PubMed Web of Science ®Google Scholar
• Scott IU, VanVeldhuisen PC, Ip MS, et al. Effect of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion: the score2 randomized clinical trial. JAMA. 2017;317:2072–2087. doi:10.1001/jama.2017.4568
   PubMed Web of Science ®Google Scholar
• Nitta Y, Kamekura N, Takuma S, Fujisawa T. Acute angle-closure glaucoma after general anesthesia for bone grafting. Anesth Prog. 2014;61:162–164. doi:10.2344/0003-3006-61.4.162
   PubMedGoogle Scholar